Clinical Trial Update: A Study Evaluating RO5479599 in Combination With Carboplatin and Paclitaxel in Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) of Squamous Histology [Phase 1, Phase 2]

View source ↗

Summary

A terminated Phase 1/2 study evaluating RO5479599 in combination with carboplatin and paclitaxel for advanced or metastatic squamous non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• RO5479599

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Squamous Non-Small Cell Lung Cancer | Phase 1, Phase 2 | Status: TERMINATED